Comparative study of the roles of cytokines and apoptosis in dilated and hypertrophic cardiomyopathies

European Cytokine Network

Volumn 15, Issue 1, 2004, Pages 53-59

  Buzás, Krisztina ^a   Megyeri, Klára ^a   Hõgye, Márta ^a   Csanády, Miklós ^a   Bogáts, Gábor ^a   Mándi, Yvette ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Apoptosis; DCM; Fas; HCM; IL 6; TNF

Indexed keywords

CYTOKINE; FAS ANTIGEN; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING ASSAY; BLOOD LEVEL; COMPARATIVE STUDY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART MUSCLE; HUMAN; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; NECROSIS; NONHUMAN; PATIENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; WESTERN BLOTTING;

ANNEXIN A5; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; CELL CYCLE PROTEINS; CELL LINE; CYTOKINES; DNA-BINDING PROTEINS; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MYOCARDIUM; NUCLEAR PROTEINS; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, INTERLEUKIN-6; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 2342562420     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Fatkin D, Graham RM. 2002. Molecular mechanisms of inherited cardiomyopathies. Phys. Rev. 82: 945.
2. Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M, Gueffet J-P, Millaire A, Desnos M, Schwartz K, Hainque B, Komajda M. 2003. Hypertrophic cardiomyopathy. Distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 107: 2227.
3. Colucci WS. 1997. Molecular and cellular mechanisms of myocardial failure. Am. J. Cardiol. 80: 15L.
4. Shan K, Kurrelmeyer K, Seta Y, Wang F, Dibbs Z, Deswal A, Lee-Jackson D, Mann DL. 1997. The role of cytokines in disease progression in heart failure. Curr. Opin. Cardiol. 12: 218.
5. Mándi Y, Hõgye M, Talha EM, Skolák E, Csanády M. 2000. Cytokine production and antibodies against heat shock protein 60 in cardiomyopathies of different origin. Pathobiology 68: 150.
6. Marshall D, Sack MN. 2000. Apoptosis: a pivotal event or an epiphenomenon in the pathophysiology of heart failure? Heart 84: 355.
7. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. 1992. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257: 387.
8. Krown KA, Page MT, Nguyen C, Zechner D, Gutierrez V, Comstock KL, Glembotski CC, Quintana PJ, Sabbadini RA. 1996. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J. Clin. Invest. 98: 2854.
9. Kubota T, Miyagishima M, Frye CS, Alber S, Bounoutas G, Kadokami T, Watkins S, McTiernan C, Feldman A. 2001. Overexpression of tumor necrosis factor-α activates both anti- and pro-apoptotic pathways in the myocardium. J. Mol. Cell. Cardiol. 33: 1331.
10. Kurrelmeyer KM, Michael LH, Baumgarten G, Taffet GE, Peschon JJ, Sivasubramanian N, Entman ML, Mann DL. 2000. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc. Natl. Acad. Sci. USA 97: 5456.
11. Song W, Lu X, Feng Q. 2000. Tumor necrosis factor-α induces apoptosis via inducible nitric oxide synthase in neonatal mouse cardiomyocytes. Cardiovasc. Res. 45: 595.
12. Lee P, Sata M, Lefer DJ, Factor SM, Walsh K, Kitsis RN. 2003. Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo. Am. J. Physiol. Heart. Physiol. 284: H456.
13. Nishigaki K, Minatoguchi S, Seishima M, Asano K, Noda T, Yasuda N, Sano H, Kumada H, Takemura M, Noma A, Tanaka T, Watanabe S, Fujiwara H. 1997. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure. J. Am. Coll. Cardiol. 29: 1214.
14. Wollert KC, Heineke J, Westermann J, Ludde M, Fiedler B, Zierh Laurent D, Bauer MK, Schulze-Osthoff K, Drexler H. 2000. The cardiac Fas (APO-1/CD95) receptor/Fas ligand system: relation to diastolic wall stress in volume-overload hypertrophy in vivo and activation of the transcription factor AP-1 in cardiac myocytes. Circulation 101: 1172.
15. Yamamura T, Nakamura H, Yamamoto T, Umemoto S, Fujii T, Kobayashi N, Matsuzaki M. 1999. Fas expression and apoptosis correlate with cardiac dysfunction in patients with dilated cardiomyopathy. Jpn. Circ. J. 63: 149.
16. Bryant D, Becker L, Richardson J, Shelton J, Franco F, Peshock R, Thompson M, Giroir B. 1998. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-α. Circulation 97: 1375.
17. Woller KC, Drexler H. 2001. The role of IL-6 in the failing heart. Heart. Fail. Rev. 6: 95.
18. Hirota H, Yoshida K, Kishimoto T, Taga T. 1995. Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc. Natl. Acad. Sci. USA 92: 4862.
19. Podewski EK, Hilfiker-Kleiner D, Hilfiker A, Morawietz H, Lichtenberg A, Wollert KC, Drexler H. 2003. Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy. Circulation 107: 798.
20. Kroemer G. 1997. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 3: 614.
21. Akyurek O, Akyurek N, Sayin T, Dincer I, Berkalp B, Akyol G, Ozenci M, Oral D. 2001. Association between the severity of heart failure and the susceptibility of myocytes to apoptosis in patients with idiopathic dilated cardiomyopathy. Int. J. Cardiol. 80: 29.
22. Chen Z, Chua CC, Ho YS, Hamdy RC, Chua BH. 2001. Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. Am. J. Physiol. Heart. Physiol. 280: H2313.
23. Diwan A, Tran T, Misra A, Mann DL. 2003. Inflammatory mediators and the failing heart: a translational approach. Curr. Mol. Med. 3: 161.
24. Feldman AM, Combes A, Wagner D, Kadokami T, Kubota T, Li YY, McTieman C. 2000. The role of tumor necrosis factor in the pathophysiology of heart failure. J. Am. Coll. Cardiol. 35: 537.
25. Yamaoka M, Yamaguchi S, Suzuki T, Okuyama M, Nitobe J, Nakamura N, Mitsui Y, Tomoike H. 2000. Apoptosis in rat cardiac myocytes induced by Fas ligand: priming for Fas-mediated apoptosis with doxorubicin. J. Mol. Cell. Cardiol. 32: 881.
26. Sliwa K, Skudicky D, Candy G, Wisenbaugh T, Sareli P. 1998. Randomised investigation of effects of pentoxifylline on left-ventricular performance idiopathic dilated cardiomyopathy. Lancet 351: 1091.
27. Wollert KC, Drexler H. 2001. The role of interleukin-6 in the failing heart. Heart Fail. Rev. 6: 95.
28. Pennica D, King KL, Shaw KJ, Luis E, Rullamas J, Luoh SM, Darbonne WC, Knutzon DS, Yen R, Chien KR. 1995. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc. Natl. Acad. Sci. USA 92: 1142.
29. Reed JC. 1994. Bcl-2 and the regulation of programmed cell death. J. Cell. Biol. 124: 1.
30. Oltvai Z, Milliman CL, Korsmeyer SJ. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609.
31. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, Mann DL. 1996. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation 93: 704.
32. Sharma R, Al-Nasser FO, Anker SD. 2001. The importance of tumor necrosis factor and lipoproteins in the pathogenesis of chronic heart failure. Heart Fail. Monit. 2: 42.